Onesource Specialty Pharma Limited has informed the Exchange about Schedule of meet
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited (formerly Stelis Biopharma) has informed the stock exchanges about its upcoming schedule of analyst and institutional investor meetings. The company will participate in a group meeting with JP Morgan on September 25, 2025, followed by a group meeting with Investec on September 29, 2025. These meetings are being disclosed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during these interactions. The schedule is subject to change due to exigencies on the part of the investor, analyst, or the company.
This is a routine regulatory disclosure with no direct financial or strategic impact for shareholders. Engagement with major institutional investors like JP Morgan and Investec may signal ongoing investor outreach, but no material new information is expected from these meetings.